- Walgreens partners with United Nations Foundation's Shot@Life campaign
- Walgreens collaborates with CDC on comprehensive HIV treatment model
- Walgreens collaborates with NMAC in expanding pneumococcal vaccine reach across HIV patients
- Chickenpox vaccine does not appear to increase incidence of shingles, study finds
- Study: Cough-cold manufacturers' voluntary label change on pediatric products reduced ER admissions
NEW YORK — Several states are cutting funding to programs that provide HIV medications to people who can’t afford them in an effort to reduce spending, according to a published report.
The Washington Post reported that more than 8,300 people are on waiting lists to obtain antiretrovirals and other drugs that treat HIV, AIDS and related conditions. The Post article highlighted particularly large program cuts in Illinois and Georgia, as well as one proposed for Florida.
The programs are designed for patients who can’t afford HIV/AIDS drugs, lack insurance or have limited coverage.